Sagittarius Life Science Corp. Statistics
Sagittarius Life Science Corp. (3205) Stock Statistics & Valuation Metrics
Total Valuation
Sagittarius Life Science Corp. has a market cap or net worth of TWD 2.96B. The enterprise value is TWD 2.96B.
- Market Cap
- TWD 2.96B
- Enterprise Value
- TWD 2.96B
Share Statistics
Sagittarius Life Science Corp. has 67,545,630 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 67,545,630
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Sagittarius Life Science Corp.’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -5.59%.
- Return on Equity (ROE)
- -0.05
- Return on Assets (ROA)
- -0.05
- Return on Invested Capital (ROIC)
- -5.59%
- Return on Capital Employed (ROCE)
- -0.06
- Revenue Per Employee
- 3.09M
- Profits Per Employee
- -442.54K
- Employee Count
- 112
- Asset Turnover
- 0.32
- Inventory Turnover
- 32.12
Valuation Ratios
The current PE Ratio of Sagittarius Life Science Corp. is -197.51. Sagittarius Life Science Corp.’s PEG ratio is -0.92.
- PE Ratio
- -197.51
- PS Ratio
- 6.54
- PB Ratio
- 2.56
- Price to FCF
- -11.70
- Price to Operating Cash Flow
- -12.17
- PEG Ratio
- -0.92
Income Statement
In the last 12 months, Sagittarius Life Science Corp. had revenue of 346.08M and earned -49.56M in profits. Earnings per share was -0.92.
- Revenue
- 346.08M
- Gross Profit
- 57.71M
- Operating Income
- -58.51M
- Pretax Income
- -49.88M
- Net Income
- -49.56M
- EBITDA
- -48.16M
- Earnings Per Share (EPS)
- -0.92
Cash Flow
In the last 12 months, operating cash flow was -210.21M and capital expenditures -50.95M, giving a free cash flow of -261.16M billion.
- Operating Cash Flow
- -210.21M
- Free Cash Flow
- -261.16M
- Free Cash Flow per Share
- -4.62
Dividends & Yields
Sagittarius Life Science Corp. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -8.54%
- Earnings Yield
- -0.66%
Stock Price Statistics
- Beta
- 0.56
- 52-Week Price Change
- -11.74%
- 50-Day Moving Average
- 46.42
- 200-Day Moving Average
- 51.12
- Relative Strength Index (RSI)
- 35.55
- Average Volume (3m)
- 31.64K
Important Dates
Sagittarius Life Science Corp. upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 11, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- ―
Financial Position
Sagittarius Life Science Corp. as a current ratio of 31.84, with Debt / Equity ratio of 0.04%
- Current Ratio
- 31.84
- Quick Ratio
- 31.50
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 3.14
- Interest Coverage Ratio
- -860.40
Taxes
In the past 12 months, Sagittarius Life Science Corp. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Sagittarius Life Science Corp. EV to EBITDA ratio is -149.64, with an EV/FCF ratio of -11.39.
- EV to Sales
- 6.36
- EV to EBITDA
- -149.64
- EV to Free Cash Flow
- -11.39
- EV to Operating Cash Flow
- -14.16
Balance Sheet
Sagittarius Life Science Corp. has TWD 635.12M in cash and marketable securities with TWD 73.60M in debt, giving a net cash position of TWD 561.52M billion.
- Cash & Marketable Securities
- TWD 635.12M
- Total Debt
- TWD 73.60M
- Net Cash
- TWD 561.52M
- Net Cash Per Share
- TWD 8.31
- Tangible Book Value Per Share
- TWD 17.74
Margins
Gross margin is 9.01%, with operating margin of -7.01%, and net profit margin of -3.60%.
- Gross Margin
- 9.01%
- Operating Margin
- -7.01%
- Pretax Margin
- -3.79%
- Net Profit Margin
- -3.60%
- EBITDA Margin
- -4.25%
- EBIT Margin
- -5.40%
Analyst Forecast
The average price target for Sagittarius Life Science Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 4.86%
- EPS Growth Forecast
- 83.87%
